Your session is about to expire
← Back to Search
Online Training Program for Dementia Care
N/A
Waitlist Available
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
Study Summary
This trial is testing whether an online training program is the same or better in improving staff competency and fidelity to principles and protocols compared to a high intensity face-to-face traditional form of training.
Who is the study for?
This trial is for individuals with dementia who are part of the Trinity PACE program, can communicate in English, and have a dedicated caregiver. Eligible staff include Occupational Therapists or Registered Nurses at PACE with over a year's experience. Exclusions apply to those with certain mental health conditions, non-responsive patients, those involved in other trials or receiving terminal care.Check my eligibility
What is being tested?
The COPE online training program for dementia care is being tested against traditional face-to-face training among PACE staff. The study will assess if online training yields equal or better outcomes in staff competency and adherence to COPE methods compared to conventional training.See study design
What are the potential side effects?
As this trial focuses on educational interventions rather than medical treatments, there are no direct side effects like you would expect from medication. However, participants may experience varying levels of stress or fatigue related to adapting new practices.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Caregiver Assessment to Function and Upset will measure change in functional ability
Secondary outcome measures
Health Related Quality of Life change
Neuropsychiatric Inventory will measure neuropychiatric symptoms change
Perceived Change for Better Index will measure change in caregiver well being
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Online training siteExperimental Treatment1 Intervention
Ten participating Trinity PACE Organizations will participate via webinar in a brief orientation/ training to the study and project logistics. Next, Trinity Health PACE organizations will be randomized into two groups using the re-randomization procedures described in the paragraph below; 5 PACE organizations will serve as the "control" site in which training will be provided via the traditional high intensity face-to-face.; 5 PACE organizations will serve as the comparison and be trained through the online training site. Prior to randomization, we will carefully examine PACE organizations on important variables such as size, location (urban; rural) percent of persons with dementia, and staff: participant ratio. In each site, one occupational therapist (OT) and one nurse (RN) will be trained (e.g., 5 OTs and 5 RNs in traditional sites; 5 OTS and 5 RNS in online training sites for a total of 10 OTs and 10 RNs or 20 health providers).
Group II: COPE-PACE participant outcomes with online trainingExperimental Treatment1 Intervention
The efficacy of the COPE program training on PACE participant outcomes by type of COPE training will be evaluated in this arm. Each of the PACE organizations will enroll 5 persons with dementia and their caregivers in the study. This will yield 50 family dyads or 100 subjects (25 dyads in traditional training sites and 25 dyads in online training sites). Dyads will be followed for 4 months. Non-inferiority analysis will be used to assess whether dyads will yield the same or better outcomes regardless of how PACE staff were trained.
Find a Location
Who is running the clinical trial?
Drexel UniversityOTHER
150 Previous Clinical Trials
47,581 Total Patients Enrolled
3 Trials studying Dementia
383 Patients Enrolled for Dementia
Thomas Jefferson UniversityOTHER
445 Previous Clinical Trials
145,369 Total Patients Enrolled
3 Trials studying Dementia
628 Patients Enrolled for Dementia
University of PennsylvaniaLead Sponsor
2,005 Previous Clinical Trials
42,882,089 Total Patients Enrolled
18 Trials studying Dementia
36,732 Patients Enrolled for Dementia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Neither I nor my partner is currently receiving treatment for a terminal illness or in hospice care.I have dementia but do not have schizophrenia or bipolar disorder.I am the main caregiver for someone with dementia, speak English, have a phone, and am willing to do 3 phone interviews.People with dementia can join if they have been diagnosed with dementia or score equal to or more than four errors on the Mental Status Questionnaire.If you have dementia and are taking a new medication to manage agitation or aggressive behaviors, you cannot participate.I am not bedbound and unresponsive due to dementia.I am a full-time OT or RN at a PACE site, employed for over a year and in good standing.
Research Study Groups:
This trial has the following groups:- Group 1: Online training site
- Group 2: COPE-PACE participant outcomes with online training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who meets the eligibility criteria to join this investigation?
"This clinical trial seeks 120 participants with Alzheimer's disease and an age between 21 to 100 years old."
Answered by AI
Does this trial encompass participants who are octogenarians or above?
"According to the inclusion criteria, patients aged 21-100 are eligible for this trial. Additionally, there are 46 trials open to minors and 814 accessible to seniors."
Answered by AI
Are any participants currently being enrolled for this trial?
"According to the information hosted by clinicaltrials.gov, this medical experiment is no longer soliciting participants. Initially posted on June 28th 2021 and most recently updated on May 16th 2022, it appears that enrolment has closed for this particular trial; however 829 other research projects are currently searching for volunteers."
Answered by AI
Who else is applying?
What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger